Clinical trials
Cardiovascular Diseases trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Active, not recruiting | 10 |
| Recruiting | 10 |
| Terminated | 6 |
| Unknown status | 5 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Norwegian University of Science and Technology | 14 |
| Oslo University Hospital | 13 |
| Novartis Pharmaceuticals | 4 |
| University Hospital, Akershus | 4 |
| Vestre Viken Hospital Trust | 4 |
| LHL Helse | 3 |
| University of Oslo | 3 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Boehringer Ingelheim | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 86 |
| Heart Diseases | 12 |
| Myocardial Infarction | 11 |
| Obesity | 9 |
| Stroke | 8 |
| Diabetes Mellitus | 7 |
| Diabetes Mellitus, Type 2 | 7 |
| Atherosclerosis | 5 |
| Atrial Fibrillation | 5 |
| Heart Failure | 5 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.